2022 - Research.com Best Scientist Award
2022 - Research.com Genetics and Molecular Biology in United Kingdom Leader Award
2018 - Member of Academia Europaea
1993 - Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases, American Academy of Neurology
1984 - Fellow of the American Association for the Advancement of Science (AAAS)
Member of the European Molecular Biology Organization (EMBO)
His primary areas of study are Genetics, Alzheimer's disease, Genome-wide association study, Disease and Single-nucleotide polymorphism. His biological study spans a wide range of topics, including Apolipoprotein E, Dementia and Degenerative disease. As a part of the same scientific study, he usually deals with the Genome-wide association study, concentrating on Quantitative trait locus and frequently concerns with Gene expression profiling and Transcriptome.
His research investigates the connection between Disease and topics such as Neuroscience that intersect with problems in Amyloid and Frontotemporal dementia. The concepts of his Single-nucleotide polymorphism study are interwoven with issues in Allele frequency and Bioinformatics. His study in Amyloid precursor protein is interdisciplinary in nature, drawing from both Transgene, Endocrinology and Presenilin.
John Hardy mainly investigates Genetics, Disease, Alzheimer's disease, Pathology and Gene. His Genetics study focuses mostly on Genome-wide association study, Locus, Allele, Single-nucleotide polymorphism and Haplotype. His research integrates issues of Genetic linkage and Linkage disequilibrium in his study of Locus.
The various areas that John Hardy examines in his Disease study include Neuroscience and Bioinformatics. His Alzheimer's disease research is multidisciplinary, incorporating perspectives in Apolipoprotein E, Endocrinology and Age of onset. His Exon and Mutation study are his primary interests in Gene.
His scientific interests lie mostly in Disease, Genetics, Genome-wide association study, Gene and Internal medicine. John Hardy has included themes like Allele and Cohort in his Disease study. His Genetics research incorporates themes from Alzheimer's disease and Frontotemporal dementia.
John Hardy interconnects Genetic variability, Expression quantitative trait loci, Genetic association and Locus in the investigation of issues within Genome-wide association study. His work in Gene covers topics such as Computational biology which are related to areas like Transcriptome and Candidate gene. His work carried out in the field of Internal medicine brings together such families of science as Polygenic risk score, Endocrinology and Oncology.
His main research concerns Disease, Genetics, Genome-wide association study, Dementia and Internal medicine. His Disease study is mostly concerned with Apolipoprotein E, Alzheimer's disease, Amyloid precursor protein and Parkinson's disease. He focuses mostly in the field of Genetics, narrowing it down to matters related to Amyotrophic lateral sclerosis and, in some cases, Age of onset.
His Genome-wide association study research is multidisciplinary, incorporating elements of Minor allele frequency, Case-control study, Genetic association and Locus. His study in Dementia is interdisciplinary in nature, drawing from both HEK 293 cells, Computational biology and Amyloid. In his research on the topic of Internal medicine, Area under the curve and Meta-analysis is strongly related with Oncology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
John Hardy;Dennis J. Selkoe.
Science (2002)
Alzheimer's disease: the amyloid cascade hypothesis
John A. Hardy;Gerald A. Higgins.
Science (1992)
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.
Alison Goate;Marie-Christine Chartier-Harlin;Mike Mullan;Jeremy Brown.
Nature (1991)
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium
I. G. McKeith;I. G. McKeith;D. W. Dickson;J. Lowe;M. Emre.
Neurology (2005)
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.
B. Winblad;K. Palmer;Miia Kivipelto;V. Jelic.
Journal of Internal Medicine (2004)
α-Synuclein Locus Triplication Causes Parkinson's Disease
A. B. Singleton;M. Farrer;J. Johnson;A. Singleton.
Science (2003)
Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
D. Scheuner;C. Eckman;C. Eckman;M. Jensen;X. Song.
Nature Medicine (1996)
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
M. Hutton;C. L. Lendon;P. Rizzu;M. Baker.
Nature (1998)
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD
Alan E. Renton;Elisa Majounie;Adrian James Waite;Javier Simón-Sánchez;Javier Simón-Sánchez.
Neuron (2011)
The amyloid hypothesis of Alzheimer's disease at 25 years
Dennis J Selkoe;John Hardy.
Embo Molecular Medicine (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
National Institutes of Health
Van Andel Institute
National Institutes of Health
University College London
Van Andel Institute
Icahn School of Medicine at Mount Sinai
University College London
University College London
University of Miami
University College London
University of Tokyo
University of Tokyo
LifeSciences Technology
Arizona State University
Indian Institute of Technology Kharagpur
University of Michigan–Ann Arbor
Karolinska Institute
Yale University
University of Georgia
COMSATS University Islamabad
University of Rennes 1
Chinese Academy of Sciences
Erasmus University Rotterdam
Michigan State University
John Radcliffe Hospital
ETH Zurich